TY - JOUR
T1 - Endoscopic revision of gastrojejunal anastomosis for the treatment of dumping syndrome in patients with Roux-en-Y gastric bypass
T2 - a systematic review and meta-analysis
AU - Bazarbashi, Ahmad Najdat
AU - Dolan, Russell D.
AU - McCarty, Thomas R.
AU - Jirapinyo, Pichamol
AU - Thompson, Christopher C.
N1 - Funding Information:
Pichamol Jirapinyo: Research support, Apollo Endosurgery, research support, Fractyl, research support, Endogastric Solutions, consultant. Christopher C. Thompson: Consultant, research support, General Partner, Advisory Board Member Apollo Endosurgery—Consultant/Research Support (Consulting fees/Institutional Research Grants), Aspire Bariatrics—Research Support (Institutional Research Grant), BlueFlame Healthcare Venture Fund—General Partner, Boston Scientific—Consultant (Consulting fees), Covidien/Medtronic—Consultant (Consulting Fees), EnVision Endoscopy (Board Member), Fractyl—Consultant/Advisory Board Member (Consulting Fees), GI Dynamics—Consultant (Consulting Fees)/ Research Support (Institutional Research Grant), GI Windows—Ownership interest, Olympus/Spiration—Consultant (Consulting Fees)/Research Support (Equipment Loans), Spatz—Research Support (Institutional Research Grant), USGI Medical—Consultant (Consulting Fees)/Advisory Board Member (Consulting fees)/Research Support (Research Grant). Authors Ahmad N. Bazarbashi, Russell D. Dolan, and Thomas R. McCarty have no conflicts of interest or financial ties to disclose.
Funding Information:
Funding was provided by National Institute of Diabetes and Digestive and Kidney Diseases (Grant No. T32 DK007533) and National Institutes of Health (Grant No. P30 DK034854).
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Dumping syndrome is a known complication of Roux-en-Y gastric bypass (RYGB). Recently, endoscopic gastrojejunal anastomosis (GJA) revision has been employed as a treatment option. The primary aim of this study was to perform a systematic review and meta-analysis for the role of endoscopic GJA revision in patients with RYGB for the treatment of dumping syndrome. Methods: Search strategies were developed for PubMed, EMBASE, Web of Science, and Cochrane Library databases from inception through December 2020 in accordance with PRISMA and MOOSE guidelines. Pooled proportions with rates estimated using random effects models were used. Outcomes included pooled technical success, clinical success, adverse events, and rate of reintervention. Heterogeneity was assessed with I2 statistics and publication bias by funnel plot using Egger and Begg tests. Results: Six studies (n = 263 patients; 60.25% female) were included (1 prospective and 5 retrospective). Mean age was 46.27 ± 2.54 years. Average patient weight was 95.59 ± 4.78 kg, BMI of 41.43 ± 3.07 kg/m2, and pre-procedure GJA size of 32.23 ± 8.68 mm. Pooled technical and clinical success was 98.15% and 89.5%. Among studies reporting Sigstad scores, endoscopic GJA revision resulted in a significant improvement [mean Sigstad score difference of − 9.96 (95% CI, − 19.951 to − 0.975); P < 0.03]. Mean procedure time was 37.12 ± 10.40 min with an intra-procedural adverse event rate of 2.42%. Over a mean follow-up of 8.03 ± 6.87 months, post-procedure adverse events occurred in 2.96% of patients with a reintervention rate of 11.54%. Conclusion: This systematic review and meta-analysis suggests that endoscopic GJA revision appears an effective and safe treatment for dumping syndrome.
AB - Background: Dumping syndrome is a known complication of Roux-en-Y gastric bypass (RYGB). Recently, endoscopic gastrojejunal anastomosis (GJA) revision has been employed as a treatment option. The primary aim of this study was to perform a systematic review and meta-analysis for the role of endoscopic GJA revision in patients with RYGB for the treatment of dumping syndrome. Methods: Search strategies were developed for PubMed, EMBASE, Web of Science, and Cochrane Library databases from inception through December 2020 in accordance with PRISMA and MOOSE guidelines. Pooled proportions with rates estimated using random effects models were used. Outcomes included pooled technical success, clinical success, adverse events, and rate of reintervention. Heterogeneity was assessed with I2 statistics and publication bias by funnel plot using Egger and Begg tests. Results: Six studies (n = 263 patients; 60.25% female) were included (1 prospective and 5 retrospective). Mean age was 46.27 ± 2.54 years. Average patient weight was 95.59 ± 4.78 kg, BMI of 41.43 ± 3.07 kg/m2, and pre-procedure GJA size of 32.23 ± 8.68 mm. Pooled technical and clinical success was 98.15% and 89.5%. Among studies reporting Sigstad scores, endoscopic GJA revision resulted in a significant improvement [mean Sigstad score difference of − 9.96 (95% CI, − 19.951 to − 0.975); P < 0.03]. Mean procedure time was 37.12 ± 10.40 min with an intra-procedural adverse event rate of 2.42%. Over a mean follow-up of 8.03 ± 6.87 months, post-procedure adverse events occurred in 2.96% of patients with a reintervention rate of 11.54%. Conclusion: This systematic review and meta-analysis suggests that endoscopic GJA revision appears an effective and safe treatment for dumping syndrome.
KW - Dumping syndrome
KW - Endoscopic gastrojejunal anastomosis revision
KW - Meta-analysis
KW - Sigstad score
UR - http://www.scopus.com/inward/record.url?scp=85117421042&partnerID=8YFLogxK
U2 - 10.1007/s00464-021-08731-4
DO - 10.1007/s00464-021-08731-4
M3 - Article
C2 - 34669046
AN - SCOPUS:85117421042
VL - 36
SP - 4099
EP - 4107
JO - Surgical Endoscopy
JF - Surgical Endoscopy
SN - 0930-2794
IS - 6
ER -